Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study
ConclusionAccording to our pan-cancer analysis,ACBD3 may serve as a remarkable prognostic and diagnostic biomarker of pan-cancers as well as contribute to tumor development.ACBD3 may also provide new directions for cancer treatment targets in the future.
Source: European Journal of Medical Research - Category: Research Source Type: research
More News: Adenocarcinoma | Adrenocortical Carcinoma | Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Glioma | Pancreas | Pancreatic Cancer | Research | Sarcomas | Statistics | Study